Member Area

Farmavita.Net - Pharmaceutical Licensing Network

Nov 29th
Innovative Medicine Demand
Innovative Arthritis Medicine


Demand: Innovative Arthritis Medicine

Farmavita.Net member is developing innovative concept for glogal branding and distribution of remedies and devices for therapy of arthritis. 

Company is looking to joint-venture, collaborative development or in-licensing of  non-prescrition products, on exclusive basis. 

For more details please contact Farmavita.Net. 

Innovative Medicines Offer
Technology Platform for Controlled and Site Specific Release of Active Pharmaceutical Ingredients

marigold_by_schroppyo.jpgFarmavita.Net member has developed technology which enables development of oral dosage forms with  controlled and site specific release of active pharmaceutical ingredients. Patent pending application.

Company is looking for following types of cooperation:
- Out-licensing
- Joint-venture and private equity partners
- Collaborative product development
- Consulting or contract research contracts

Generic Medicine Demand
Felodipine Extended Release Tablets Member of  Farmavita.Net from EU is looking to in-license Felodipine 5 and 10 mg Extended Release Tablets
Dossier should be already authorized in European Union
They are looking for duplicate Dossier authorization in Cyprus. 
Generic Medicines - Offer
Pregabalin We offer for outlicensing European e-CTD format of Pregabalin caps (whole strength range). Dossier is ready and has been approved/registered in several EU countries. Preferred model is of business cooperation is License Fee + Supply with finished product.
OTC / Nutraceutical Demand
Trypsin and Chymotrypsin Tablets

Demand for  Trypsin and  Chymotrypsin  Tablets 

Member of Farmavita.Net is looking for contract manufacturer of Trypsin and  Chymotrypsin Enteric Coated Tablets

Intendent use is  for improper flow of blood and lymph, retention of body  fluids, In case of increased accumulation of secretions in the sinuses and the bronchi.

API/Technology Demand
Seeking: Fermentation technology of Pristinamycin


An Asia based international company is looking for technologies in the following field:

Type of Tech Request: Licensing

Desired outcome:

Pristinamycin (CAS No:270076-60-3) is an antibiotic used primarily in the treatment of staphylococcal infections, and to a lesser extent streptococcal infections. We’re looking for a technology of Pristinamycin based on fermentation. Both of the strain and the process are included.

The technology should have over 5000u/ml fermentation titre and other competitive parameters, and not infringe on other patents and intellectual property right. It is better that it can be directly used for APIs industrial production.
Life Science Article
Analgesic Activity of Murdannia nudiflora (L) Brenan


Phytochemical Standardization and Analgesic Activity of Murdannia nudiflora (L) Brenan

Our present communication deals with physicochemical parameters, preliminary phytochemical studies and pharmacological impact of Murdannia nudiflora (L) Brenan as analgesic plant which is used in folklore uses of Assam. No reports are available on standardization parameters hence, the present attempt was undertaken to investigate the standardization parameters to establish its authenticity. The study revealed the presence of wide range of phytoconstituents. The determination of these characters will aid future investigators in their Pharmacological analysis of this species. 

The whole 8 pages article is available for download at Downloads section of Farmavita.Net. 
Medical Affairs Leaders Forum Europe

6th Edition Medical Affairs Leaders Forum Europe (Spring)

22nd - 23rd February, 2015, Berlin, Germany


This 2 day forum is the "must attend" event for those senior decision-makers looking to drive their medical affairs teams and departments and enhance their KOL & stakeholder engagement at all levels. 


Featured Partners


Follow us on:

Join our LinkedIn Group

BabelFish Translator

Click Flag for Translation

Who's Online

We have 59 guests online

Farmavita.Net RSS News